您的位置: 首页 > 农业专利 > 详情页

Lentiviral vectors for regulated expression of a chimeric antigen receptor molecule
专利权人:
THERAVECTYS;INSTITUT CURIE;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE;UNIVERSITE PIERRE ET MARIE CURIE;INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
发明人:
Sophie Agaugue,Lorenzo Tibaldi,Klervi Even-Desrumaux,Dmitry Trubetskoy,Franck Perez,Sebastian Amigorena,Cécile Bauche
申请号:
US15327517
公开号:
US10752668B2
申请日:
2015.07.24
申请国别(地区):
US
年份:
2020
代理人:
摘要:
The invention relates to the regulated expression of a chimeric antigen receptor (CAR) within a lentiviral vector. The CAR comprises a hook-binding domain that interacts with a hook, preferably encoded by the same lentiviral vector, which prevents proper processing and release of the CAR to the cell membrane. The invention encompasses vectors, methods of making the vectors, and methods of using them, including medicinal uses. The vectors can be used for administration to humans to induce immune responses and to treat cancers and tumors.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充